OLEMA PHARMACEUTICALS

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 2月 2023 18:00:40 条件 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 1月 2023 16:30:01 条件 Nasdaq GlobeNewswire

Olema Oncology to Present at 41st Annual J.P. Morgan Healthcare Conference

03 1月 2023 07:00:58 条件 Nasdaq GlobeNewswire

Olema Oncology Announces OP-1250 Demonstrates Attractive Combinability with CDK 4/6 Inhibitor Palbociclib in Phase 1b Dose Escalation Study

07 12月 2022 15:37:49 条件 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 12月 2022 16:30:00 条件 Nasdaq GlobeNewswire

Olema Oncology Announces Poster Presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS)

21 11月 2022 09:16:07 条件 Nasdaq GlobeNewswire

Olema Oncology Reports Third Quarter 2022 Financial Results and Provides Corporate Update

08 11月 2022 16:30:00 条件 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 11月 2022 16:30:00 条件 Nasdaq GlobeNewswire

Olema Oncology to Present at Upcoming Investor Conferences in November

01 11月 2022 08:00:02 条件 Nasdaq GlobeNewswire

Olema Oncology Announces Complete ER Antagonist OP-1250 Continues to Demonstrate Robust Activity in Phase 1/2 Clinical Trial

26 10月 2022 03:00:00 条件 Nasdaq GlobeNewswire

Olema Oncology Announces Upcoming Clinical Data Poster Presentation at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

12 10月 2022 07:01:00 条件 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 10月 2022 16:29:00 条件 Nasdaq GlobeNewswire

Olema Oncology to Present at H.C. Wainwright 24th Annual Global Investment Conference

06 9月 2022 16:30:00 条件 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 9月 2022 17:01:48 条件 Nasdaq GlobeNewswire

Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate Update

09 8月 2022 16:35:00 条件 Nasdaq GlobeNewswire

Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast Cancer

09 8月 2022 16:30:00 条件 Nasdaq GlobeNewswire

Olema Oncology to Present at Canaccord Genuity 42nd Annual Growth Conference

04 8月 2022 16:30:00 条件 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 8月 2022 16:30:00 条件 Nasdaq GlobeNewswire

Olema Oncology Receives FDA Fast Track Designation for OP-1250 for the Treatment of ER+ / HER2- Metastatic Breast Cancer

21 7月 2022 07:30:00 条件 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 7月 2022 16:30:00 条件 Nasdaq GlobeNewswire